Key result
Novel balloon-expandable polymer-leaflet TAVR system shows excellent fluid dynamics and fatigue resistance in preclinical testing.
Why the study?
Leaflet durability and costs restrict contemporary TAVR largely to elderly patients in affluent countries, highlighting the need for valves deployable without rapid pacing, suitable for younger patients, and able to anchor in non-calcific aortic regurgitation.
Answers are grounded in this paper and cite their sources.
A novel balloon-expandable TAVR system utilizing polymer leaflets and designed for non-calcific anchorage demonstrated excellent in vitro hemodynamics and durability, suggesting potential for use in younger patients and those with rheumatic heart disease.
Leaflet durability and costs restrict contemporary trans-catheter aortic valve replacement (TAVR) largely to elderly patients in affluent countries. TAVR that are easily deployable, avoid secondary procedures and are also suitable for younger patients and non-calcific aortic regurgitation (AR) would significantly expand their global reach. Recognizing the reduced need for post-implantation pacemakers in balloon-expandable (BE) TAVR and the recent advances with potentially superior leaflet materials, a trans-catheter BE-system was developed that allows tactile, non-occlusive deployment without rapid pacing, direct attachment of both bioprosthetic and polymer leaflets onto a shape-stabilized scallop and anchorage achieved by plastic deformation even in the absence of calcification. Three sizes were developed from nickel-cobalt-chromium MP35N alloy tubes: Small/23 mm, Medium/26 mm and Large/29 mm. Crimp-diameters of valves with both bioprosthetic (sandwich-crosslinked decellularized pericardium) and polymer leaflets (triblock polyurethane combining siloxane and carbonate segments) match those of modern clinically used BE TAVR. Balloon expansion favors the wing-structures of the stent thereby creating supra-annular anchors whose diameter exceeds the outer diameter at the waist level by a quarter. In the pulse duplicator, polymer and bioprosthetic TAVR showed equivalent fluid dynamics with excellent EOA, pressure gradients and regurgitation volumes. Post-deployment fatigue resistance surpassed ISO requirements. The radial force of the helical deployment balloon at different filling pressures resulted in a fully developed anchorage profile of the valves from two thirds of their maximum deployment diameter onwards. By combining a unique balloon-expandable TAVR system that also caters for non-calcific AR with polymer leaflets, a powerful, potentially disruptive technology for heart valve disease has been incorporated into a TAVR that addresses global needs. While fulfilling key prerequisites for expanding the scope of TAVR to the vast number of patients of low- to middle income countries living with rheumatic heart disease the system may eventually also bring hope to patients of high-income countries presently excluded from TAVR for being too young.
No takes yet. Share an insight, caveat, or question.
Appa et al. (2022) studied Aortic Regurgitation. SAT balloon-expandable TAVR system was evaluated. A novel balloon-expandable TAVR system utilizing plastic deformation for anchorage and polymer leaflets demonstrated excellent fluid dynamics and fatigue resistance in preclinical testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: